Nucleai is committed to bringing the power of spatial biology to reality by providing pharmaceutical companies and clinicians with AI-powered image analysis applications. Nucleai's image analysis and biomarker discovery technology leverages real-world pathology, clinical and molecular datasets to better understand cancer biology, optimize patient stratification and improve patient care. Their algorithms for the analysis of pathology slides detect and characterize tissue and cell architecture, and their deep learning models drive the discovery of pathology-based spatial biomarkers.